Modern biotechnology applies genetic understanding to real, practical applications: gene editing tools like CRISPR allow scientists to precisely target and modify specific sequences within an organism's DNA, opening possibilities for treating genetic diseases, improving crops, and researching gene function. Genetic engineering more broadly involves inserting, deleting or modifying genes to produce a desired trait — as seen in genetically modified crops engineered for pest resistance, or in using bacteria genetically modified to produce human insulin at scale. These technologies raise genuine, ongoing ethical and regulatory questions — around safety, environmental impact, access and equity, and where the boundaries of acceptable genetic modification should be drawn, particularly regarding modifications that could be inherited by future generations.
Example
Before genetic engineering, insulin for treating diabetes was extracted from animal pancreases — a limited, expensive and sometimes less compatible source; today, bacteria genetically modified with the human insulin gene produce human insulin directly and at a massive scale, a genuine biotechnology application that has made treatment more accessible and effective for millions of people worldwide.
Key terms
CRISPR:
A gene-editing tool allowing scientists to precisely target and modify specific DNA sequences.
Genetic engineering:
Inserting, deleting or modifying genes to produce a desired trait in an organism.
Questions
1. CRISPR is a tool used to:
Precisely target and modify specific DNA sequences
Have no connection to genetics at all
Only observe DNA, with no ability to modify it
Randomly and uncontrollably alter an entire genome
2. Genetic engineering involves:
Inserting, deleting or modifying genes to produce a desired trait
Only observing genes with no modification involved
A process unrelated to genes or traits
Something that never actually occurs in real science
3. Bacteria genetically modified to produce human insulin is an example of:
A practical biotechnology application
Something with no real-world use
A purely theoretical concept never actually implemented
A process unrelated to genetic engineering
4. Genetically modified crops can be engineered for:
Pest resistance
No purpose at all
Only decorative appearance, with no functional benefit
Nothing at all; there are no ethical questions involved
Only questions unrelated to genetics
Only questions about cost, with nothing else relevant
6. Modifications that could be inherited by future generations raise particular concern because:
Their effects could extend beyond the individual being treated
They never actually have any effect beyond the individual treated
Inherited modifications are considered no different from any other modification
This kind of modification is not actually possible with current technology
7. Before genetic engineering, insulin for diabetes treatment was extracted from:
Animal pancreases
Bacteria genetically modified for this purpose
A source with no connection to animals
A purely synthetic, non-biological process
8. Why might using genetically modified bacteria to produce human insulin be considered a significant improvement over extracting insulin from animal pancreases?
It allows insulin to be produced at a much larger scale, more consistently, and with better compatibility for human use than a more limited animal-derived source
Producing insulin from genetically modified bacteria provides no genuine advantage over extracting it from animal pancreases
Animal-derived insulin was always exactly as scalable, consistent and compatible with human use as bacterially produced insulin
This kind of biotechnology application has never actually been used in real, practical insulin production
9. Why might CRISPR be considered a more precise gene-editing tool than earlier genetic modification techniques?
It can target and edit a specific DNA sequence directly, reducing the risk of unintended changes elsewhere in the genome compared to less targeted, earlier methods
CRISPR is always exactly as imprecise and untargeted as any earlier genetic modification technique
The precision of a gene-editing tool has no bearing on how effectively or safely it can be used
Earlier genetic modification techniques were always more precise and targeted than CRISPR
10. Why might genetically modifying crops for pest resistance potentially reduce the need for chemical pesticides?
If the crop itself is engineered to resist common pests, farmers may need to apply fewer external chemical treatments to protect the same yield
Genetically modifying crops for pest resistance always increases the need for additional chemical pesticide use
Pest resistance engineered into a crop has no genuine connection to how much pesticide a farmer might need to apply
Chemical pesticides and genetically engineered pest resistance are always used in identical amounts regardless of the crop's genetic modification
11. Why might scientists researching gene function in a laboratory setting use CRISPR to deliberately "knock out" (disable) a specific gene in a test organism?
Observing what changes occur when a specific gene is disabled can reveal what normal biological function that gene actually contributes to, providing insight into its role
Deliberately disabling a specific gene in a laboratory organism never actually reveals any useful information about that gene's normal function
Gene function research never actually makes any practical use of gene-editing tools like CRISPR
Disabling a gene always has an identical, predictable effect regardless of what that gene's normal biological role actually is
12. Why might a genetically modified crop still require monitoring for unintended effects on non-target species (like beneficial insects), even if it successfully resists its intended pest?
A modification aimed at one specific pest could still have unforeseen effects on other organisms within the same ecosystem, so broader ecological impact needs separate consideration beyond just the intended pest-resistance outcome
A genetically modified crop can never actually have any effect on organisms other than the specific pest it was engineered to resist
Monitoring for effects on non-target species provides no genuine additional value once a crop's intended pest resistance has been confirmed
Ecological impact on beneficial insects and other non-target species is always completely unrelated to a crop's genetic modification
13. Why might genetic modifications affecting only an individual's own body cells raise different ethical considerations than modifications that could be passed on to future generations?
Changes limited to an individual affect only that person's own consent and outcomes, while heritable changes could affect descendants who have no ability to consent to the modification
These two types of genetic modification always raise exactly identical ethical considerations with no meaningful distinction
Whether a genetic modification can be inherited by future generations has no bearing on the ethical considerations it raises
Only modifications affecting an individual's own body cells ever raise any genuine ethical questions
14. Why might equitable access to genetic technologies (like advanced gene therapies) be a genuine concern as these technologies continue to develop?
If these technologies remain expensive or limited in availability, they could primarily benefit those who can already afford access, potentially widening existing health inequalities
Equitable access to genetic technologies has no genuine connection to broader questions about health inequality
Every genetic technology, regardless of cost, is always equally accessible to everyone across every level of income
The cost and availability of genetic technologies never actually has any bearing on who is able to benefit from them
15. Why might regulatory bodies require extensive testing and review before approving a genetically modified organism for widespread agricultural or medical use?
Genetic modifications can have unintended, sometimes hard-to-predict effects on health or ecosystems, so careful testing helps identify and manage risks before widespread release
Genetically modified organisms never actually require any testing or regulatory review before being approved for use
Extensive testing and review of genetically modified organisms provides no genuine benefit or risk reduction
Every genetic modification always produces exactly predictable outcomes, removing any need for careful regulatory review
16. Why might the possibility of using gene-editing technology for non-medical trait selection (rather than treating disease) raise particularly difficult ethical questions?
It raises questions about where to draw the line between treating genuine medical need and altering traits for other reasons, touching on deeper questions about equity, consent and what kind of genetic diversity society values
Using gene-editing technology for non-medical trait selection raises no ethical questions or concerns of any genuine kind
There is a universally agreed, completely uncontroversial line between medical and non-medical uses of gene-editing technology
This kind of ethical question has no genuine connection to broader questions about equity or societal values
17. Why might international cooperation and shared regulatory standards be considered important for genetic technologies, given that research and applications occur across many different countries?
Without some level of shared standards, differing regulations between countries could create loopholes, safety inconsistencies, or ethical concerns that a purely national approach to regulation might not adequately address
International cooperation and shared regulatory standards provide no genuine benefit for governing genetic technologies that span multiple countries
Every country always maintains exactly identical regulatory standards for genetic technology, making cooperation unnecessary
Genetic technology research and applications only ever occur within the borders of a single country, with no international dimension
18. Why might scientists and ethicists argue that public understanding and engagement with genetic technology is important, not just decisions made by scientists or regulators alone?
These technologies can have significant, wide-reaching societal implications, so broader public understanding supports more informed, democratically legitimate decisions about how they should be used and regulated
Public understanding and engagement with genetic technology has no genuine relevance to decisions about how it should be used or regulated
Decisions about genetic technology should always be made exclusively by scientists and regulators, with no role for broader public engagement
Genetic technologies never actually have any significant societal implications that would require broader public understanding or input
19. Why might CRISPR's relative simplicity and lower cost compared to earlier gene-editing techniques raise both opportunity and new regulatory challenges simultaneously?
Greater accessibility can accelerate beneficial research and applications, but also makes it harder to ensure consistent oversight if more, and more varied, groups are able to use the technology
Greater accessibility to a gene-editing technology never actually raises any genuine regulatory challenge or concern
CRISPR being simpler and cheaper than earlier techniques has no bearing on either research opportunity or regulatory oversight
Lower cost and greater accessibility only ever create challenges, with no accompanying research or medical opportunity
20. Why might long-term monitoring of genetically modified organisms (after initial approval) still be considered necessary, even after they have already passed rigorous pre-release testing?
Some effects, particularly on complex ecosystems or over multiple generations, may only become apparent over a longer timeframe than initial testing can practically capture
Once a genetically modified organism passes initial testing, no further monitoring is ever considered necessary or useful
Long-term ecological or health effects of genetic modification are always fully captured by short-term pre-release testing alone
Ongoing monitoring after approval provides no genuine additional insight beyond what initial testing already established
21. Understanding genetic technology and biotechnology applications mainly helps you to:
Evaluate the scientific capabilities and genuine ethical and regulatory questions raised by modern genetic technologies
Assume genetic engineering has no real-world practical applications beyond theoretical research
Ignore the distinction between modifications affecting an individual versus those that could be inherited
Treat equitable access to genetic technologies as an irrelevant consideration
Answer key (parent copy)
1. Precisely target and modify specific DNA sequences
2. Inserting, deleting or modifying genes to produce a desired trait
3. A practical biotechnology application
4. Pest resistance
5. Safety, environmental impact and access
6. Their effects could extend beyond the individual being treated
7. Animal pancreases
8. It allows insulin to be produced at a much larger scale, more consistently, and with better compatibility for human use than a more limited animal-derived source
9. It can target and edit a specific DNA sequence directly, reducing the risk of unintended changes elsewhere in the genome compared to less targeted, earlier methods
10. If the crop itself is engineered to resist common pests, farmers may need to apply fewer external chemical treatments to protect the same yield
11. Observing what changes occur when a specific gene is disabled can reveal what normal biological function that gene actually contributes to, providing insight into its role
12. A modification aimed at one specific pest could still have unforeseen effects on other organisms within the same ecosystem, so broader ecological impact needs separate consideration beyond just the intended pest-resistance outcome
13. Changes limited to an individual affect only that person's own consent and outcomes, while heritable changes could affect descendants who have no ability to consent to the modification
14. If these technologies remain expensive or limited in availability, they could primarily benefit those who can already afford access, potentially widening existing health inequalities
15. Genetic modifications can have unintended, sometimes hard-to-predict effects on health or ecosystems, so careful testing helps identify and manage risks before widespread release
16. It raises questions about where to draw the line between treating genuine medical need and altering traits for other reasons, touching on deeper questions about equity, consent and what kind of genetic diversity society values
17. Without some level of shared standards, differing regulations between countries could create loopholes, safety inconsistencies, or ethical concerns that a purely national approach to regulation might not adequately address
18. These technologies can have significant, wide-reaching societal implications, so broader public understanding supports more informed, democratically legitimate decisions about how they should be used and regulated
19. Greater accessibility can accelerate beneficial research and applications, but also makes it harder to ensure consistent oversight if more, and more varied, groups are able to use the technology
20. Some effects, particularly on complex ecosystems or over multiple generations, may only become apparent over a longer timeframe than initial testing can practically capture
21. Evaluate the scientific capabilities and genuine ethical and regulatory questions raised by modern genetic technologies